Indofarma Tbk. vs Onix Capital Tbk. — how do they compare? Indofarma Tbk. trades at Rp126 (market cap 390.51B), while Onix Capital Tbk. trades at Rp159 (market cap 43.44B). The key difference: Indofarma Tbk. is far larger — about 9× Onix Capital Tbk.'s market cap. Which is the better fit depends on your goals.
| INAF | OCAP | |
|---|---|---|
Market Cap | 390.51B | 43.44B |
Trailing returns across standard periods
Latest headlines on both assets
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Read more on INAF →PT Onix Capital Tbk (formerly PT JJ NAB Capital Tbk), was established with the initial establishment of PT Piranti Ciptadhana Amerta based on Notarial Deed No 30 dated October 6, 1989 of Amrul Partomuan Pohan, S.H., LLM, Public notary in Jakarta. Based on Notarial Deed No. 4 dated December 14, 2007 of Andalia Farida, S.H., M.h., public notary in Jakarta, the Company changed its name from PT Okansa Capital Tbk to PT JJ NAB Capital Tbk.
Read more on OCAP →